Merck KGaA, Valo to Use AI for Parkinson’s in $3 Billion Deal
Merck KGaA, a German science group, will use Valo Health Inc.’s AI platform to help discover and develop treatments for Parkinson’s disease and related disorders, in a partnership deal that could be worth more than $3 billion.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
